Ipragliflozin lowers small, dense low-density lipoprotein cholesterol levels in Japanese patients with type 2 diabetes mellitus

AIMS: This preliminary randomized, parallel-group comparative study evaluated the efficacy of ipragliflozin for reduction of small dense low-density lipoprotein cholesterol (sd LDL-C) levels in Japanese patients with type 2 diabetes mellitus (T2DM). METHODS: Sixty-two patients with T2DM (age, 56 ± 8...

Descripción completa

Detalles Bibliográficos
Autores principales: Bando, Yukihiro, Tohyama, Hitomi, Aoki, Keiko, Kanehara, Hideo, Hisada, Azusa, Okafuji, Kazuhiro, Toya, Daisyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644427/
https://www.ncbi.nlm.nih.gov/pubmed/29067237
http://dx.doi.org/10.1016/j.jcte.2016.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644427/
https://www.ncbi.nlm.nih.gov/pubmed/29067237
http://dx.doi.org/10.1016/j.jcte.2016.06.001

Ejemplares similares